First Header Logo Second Header Logo

Gregory Kucera

Concepts (185)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
22
2017
608
1.520
Why?
Platinum
11
2014
21
1.090
Why?
Acridines
13
2014
19
1.070
Why?
Deoxycytidine
3
2017
68
0.610
Why?
Organoplatinum Compounds
5
2014
46
0.430
Why?
Thiourea
5
2015
5
0.420
Why?
Cell Line, Tumor
18
2020
726
0.390
Why?
Neoplasms
4
2019
728
0.390
Why?
Nucleosides
2
2016
10
0.380
Why?
Prodrugs
2
2014
16
0.370
Why?
DNA
7
2014
226
0.370
Why?
Drug Design
8
2014
43
0.350
Why?
Intercalating Agents
5
2014
9
0.350
Why?
Lipids
2
2016
232
0.340
Why?
Ovarian Neoplasms
2
2007
96
0.320
Why?
Drug Screening Assays, Antitumor
12
2017
58
0.300
Why?
Drug Resistance, Neoplasm
3
2017
104
0.290
Why?
Hyperthermia, Induced
2
2007
243
0.290
Why?
Nitrobenzenes
1
2006
10
0.280
Why?
Cyclooxygenase 2 Inhibitors
1
2006
15
0.280
Why?
HL-60 Cells
5
2008
14
0.270
Why?
Sulfonamides
1
2006
67
0.270
Why?
DNA Damage
4
2017
99
0.270
Why?
Cytarabine
2
2017
55
0.260
Why?
Antimetabolites, Antineoplastic
1
2005
49
0.250
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2017
458
0.240
Why?
Phosphatidic Acids
1
2003
1
0.230
Why?
Apoptosis
4
2017
360
0.230
Why?
Coordination Complexes
2
2015
9
0.210
Why?
Gold
2
2015
18
0.210
Why?
Humans
31
2020
32114
0.210
Why?
Anisomycin
1
2002
3
0.200
Why?
Protein Synthesis Inhibitors
1
2002
11
0.200
Why?
Mitoxantrone
1
2002
19
0.200
Why?
Mitogen-Activated Protein Kinases
1
2002
37
0.200
Why?
Structure-Activity Relationship
10
2014
80
0.200
Why?
DNA Adducts
5
2014
12
0.190
Why?
Citric Acid Cycle
1
2020
11
0.180
Why?
Pyruvate Dehydrogenase Complex
1
2020
18
0.180
Why?
Urea
3
2009
37
0.180
Why?
DNA, Neoplasm
3
2013
55
0.180
Why?
AMP-Activated Protein Kinases
1
2020
37
0.180
Why?
Tissue Array Analysis
1
2019
34
0.170
Why?
Lung Neoplasms
4
2014
414
0.160
Why?
Myeloid Cells
1
2019
39
0.160
Why?
Adenine
2
2010
16
0.160
Why?
Cell Proliferation
4
2015
604
0.150
Why?
Glycerophosphates
1
2017
4
0.150
Why?
Tumor Cells, Cultured
3
2006
171
0.140
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
44
0.140
Why?
Solubility
3
2008
36
0.140
Why?
Breast Neoplasms
2
2020
765
0.130
Why?
Prodigiosin
2
2006
2
0.120
Why?
Protein Kinase Inhibitors
1
2015
85
0.120
Why?
Cell Cycle
1
2014
77
0.110
Why?
Cisplatin
3
2012
76
0.110
Why?
Antineoplastic Agents, Hormonal
1
2013
42
0.110
Why?
Inhibitory Concentration 50
3
2015
22
0.110
Why?
Microscopy, Confocal
1
2013
65
0.110
Why?
Drug Delivery Systems
1
2014
104
0.110
Why?
Tamoxifen
1
2013
59
0.110
Why?
Fluorescent Dyes
1
2013
48
0.110
Why?
Carboxylic Acids
1
2012
2
0.110
Why?
Small Molecule Libraries
1
2012
11
0.110
Why?
Dose-Response Relationship, Drug
5
2017
633
0.100
Why?
Chelating Agents
2
2009
17
0.100
Why?
Animals
7
2020
7542
0.100
Why?
Spectrometry, Mass, Electrospray Ionization
4
2012
33
0.100
Why?
Chromatography, High Pressure Liquid
4
2012
94
0.090
Why?
Cell Survival
3
2020
285
0.090
Why?
Alkylating Agents
1
2010
5
0.090
Why?
Mycobacterium tuberculosis
1
2009
6
0.090
Why?
Organogold Compounds
1
2009
4
0.090
Why?
Antitubercular Agents
1
2009
8
0.090
Why?
Platinum Compounds
1
2009
3
0.080
Why?
2,2'-Dipyridyl
1
2009
3
0.080
Why?
Cell Line
2
2015
435
0.080
Why?
Guanidine
1
2008
3
0.080
Why?
Combined Modality Therapy
2
2007
560
0.080
Why?
Carboplatin
1
2007
48
0.070
Why?
Alkaloids
1
2006
9
0.070
Why?
Dinoprostone
1
2006
31
0.070
Why?
Drug Synergism
1
2006
66
0.070
Why?
Cyclooxygenase 2
1
2006
48
0.070
Why?
Taxoids
1
2006
59
0.070
Why?
Signal Transduction
2
2020
682
0.070
Why?
Deoxycytidine Kinase
1
2005
2
0.060
Why?
Phospholipids
1
2005
28
0.060
Why?
Mice, Nude
2
2020
291
0.060
Why?
Enzyme Activation
2
2020
135
0.060
Why?
Monoterpenes
1
2004
3
0.060
Why?
Genes, Neoplasm
1
2004
18
0.060
Why?
Stereoisomerism
3
2008
22
0.060
Why?
Buffers
1
2003
9
0.060
Why?
Ribonucleotide Reductases
1
2003
6
0.060
Why?
Biological Availability
2
2016
21
0.060
Why?
Rhodium
1
2002
1
0.050
Why?
Organometallic Compounds
1
2002
23
0.050
Why?
Models, Molecular
3
2008
193
0.050
Why?
Female
5
2020
20015
0.050
Why?
Precipitin Tests
1
2002
14
0.050
Why?
JNK Mitogen-Activated Protein Kinases
1
2002
14
0.050
Why?
Flavonoids
1
2002
18
0.050
Why?
Leukemia, Myeloid
1
2002
24
0.050
Why?
Mitogen-Activated Protein Kinase 3
1
2002
43
0.050
Why?
p38 Mitogen-Activated Protein Kinases
1
2002
36
0.050
Why?
Pyridines
1
2002
76
0.050
Why?
Imidazoles
1
2002
91
0.050
Why?
Transfection
1
2002
191
0.050
Why?
Blotting, Western
1
2002
289
0.050
Why?
Mice
3
2014
2484
0.050
Why?
Phosphoserine
1
2020
8
0.050
Why?
Catalytic Domain
1
2020
65
0.050
Why?
Water
2
2012
56
0.050
Why?
Stress, Physiological
1
2020
55
0.050
Why?
Mice, Inbred BALB C
1
2020
167
0.040
Why?
Phosphorylation
1
2020
229
0.040
Why?
Tissue Fixation
1
2019
10
0.040
Why?
Neoplasm Metastasis
1
2020
220
0.040
Why?
Paraffin Embedding
1
2019
10
0.040
Why?
Formaldehyde
1
2019
11
0.040
Why?
Survival Analysis
1
2020
483
0.040
Why?
Crystallography, X-Ray
2
2009
90
0.040
Why?
Philadelphia Chromosome
1
2017
4
0.040
Why?
Protein Kinase C
1
2017
31
0.040
Why?
Tumor Burden
1
2017
58
0.040
Why?
Neoplasm Transplantation
1
2017
73
0.040
Why?
Doxorubicin
1
2017
82
0.040
Why?
Random Allocation
1
2017
228
0.030
Why?
Mice, Transgenic
1
2017
264
0.030
Why?
Molecular Structure
2
2008
59
0.030
Why?
Photochemistry
2
2006
7
0.030
Why?
Quinazolines
1
2015
38
0.030
Why?
G-Quadruplexes
1
2014
8
0.030
Why?
Hydrolysis
1
2014
35
0.030
Why?
Valproic Acid
1
2014
14
0.030
Why?
Mice, Inbred C57BL
1
2017
767
0.030
Why?
Carcinoma, Non-Small-Cell Lung
1
2014
101
0.030
Why?
Flow Cytometry
1
2014
185
0.030
Why?
Hydrazines
1
2013
4
0.030
Why?
Carcinoma, Squamous Cell
1
2014
154
0.030
Why?
Esters
1
2012
10
0.030
Why?
Receptors, Estrogen
1
2013
113
0.030
Why?
Chromatography, Reverse-Phase
1
2012
1
0.030
Why?
Cell-Free System
1
2012
15
0.030
Why?
Adenocarcinoma
1
2014
308
0.020
Why?
DNA Cleavage
1
2010
4
0.020
Why?
Netropsin
1
2010
3
0.020
Why?
Vero Cells
1
2009
3
0.020
Why?
DNA, Bacterial
1
2009
27
0.020
Why?
Ligands
1
2009
81
0.020
Why?
Chemistry, Pharmaceutical
1
2008
11
0.020
Why?
Polydeoxyribonucleotides
1
2008
1
0.020
Why?
Models, Chemical
1
2008
34
0.020
Why?
Circular Dichroism
1
2008
30
0.020
Why?
Nucleic Acid Conformation
1
2008
48
0.020
Why?
Hematologic Diseases
1
2007
23
0.020
Why?
Infusions, Parenteral
1
2007
65
0.020
Why?
Sulfur Compounds
1
2006
7
0.020
Why?
Base Sequence
1
2007
252
0.020
Why?
Molecular Sequence Data
1
2007
359
0.020
Why?
Hydrogen Bonding
1
2006
22
0.020
Why?
Neoplasm Staging
1
2007
447
0.020
Why?
Oxidation-Reduction
1
2006
268
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2004
10
0.010
Why?
Genes, p53
1
2004
23
0.010
Why?
Genes, ras
1
2004
26
0.010
Why?
Caspase 3
1
2004
33
0.010
Why?
Caspases
1
2004
39
0.010
Why?
Cloning, Molecular
1
2004
75
0.010
Why?
Cell Division
1
2004
99
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
160
0.010
Why?
Down-Regulation
1
2004
142
0.010
Why?
Up-Regulation
1
2004
189
0.010
Why?
Time Factors
1
2008
2151
0.010
Why?
Chemistry
1
2002
2
0.010
Why?
Chemical Phenomena
1
2002
3
0.010
Why?
Electrophoresis, Agar Gel
1
2002
14
0.010
Why?
Cattle
1
2002
103
0.010
Why?
Magnetic Resonance Spectroscopy
1
2002
83
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2004
261
0.010
Why?
Escherichia coli
1
2002
87
0.010
Why?
DNA Fragmentation
1
2002
7
0.010
Why?
Mutation
1
2004
489
0.010
Why?
Middle Aged
1
2007
11839
0.010
Why?
Kucera's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (185)
Explore
_
Co-Authors (18)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_